---
ver: rpa2
title: 'PiPViT: Patch-based Visual Interpretable Prototypes for Retinal Image Analysis'
arxiv_id: '2506.10669'
source_url: https://arxiv.org/abs/2506.10669
tags:
- pipvit
- prototypes
- image
- drusen
- classification
- transformers
- self-attention
- retrieval-augmented-generation
- instruction-tuning
- parameter-efficient-finetuning
- mixture-of-experts
- chain-of-thought
core_contribution: PiPViT introduces a prototype-based vision transformer model for
  retinal OCT image classification that addresses the limitations of existing approaches
  by learning semantically meaningful, interpretable prototypes that approximate lesion
  extent. The model leverages a ViT backbone to capture long-range dependencies among
  patches, combined with contrastive learning and multi-resolution pre-training to
  enhance prototype quality and generalizability.
---

# PiPViT: Patch-based Visual Interpretable Prototypes for Retinal Image Analysis

## Quick Facts
- arXiv ID: 2506.10669
- Source URL: https://arxiv.org/abs/2506.10669
- Authors: Marzieh Oghbaie; Teresa Araújo; Hrvoje Bogunović
- Reference count: 40
- Key outcome: Prototype-based ViT model achieves BAcc: 0.888±0.048 on retinal OCT classification with interpretable prototypes

## Executive Summary
PiPViT introduces a novel prototype-based vision transformer approach for retinal OCT image classification that bridges the gap between model interpretability and clinical utility. By learning semantically meaningful prototypes that approximate lesion extent, the model provides explanations that are both clinically relevant and visually interpretable. The architecture leverages a ViT backbone with contrastive learning and multi-resolution pre-training to capture long-range dependencies among patches while maintaining interpretability through prototype learning.

## Method Summary
PiPViT combines a Vision Transformer backbone with prototype-based learning to create interpretable models for retinal OCT image analysis. The approach uses patch embedding to capture spatial relationships, contrastive learning to enhance prototype quality, and multi-resolution pre-training to improve generalizability across datasets. Prototypes are learned to represent semantically meaningful regions corresponding to key biomarkers like intra-retinal fluid, drusen, and geographic atrophy, with class-specific weighting determining their importance for classification decisions.

## Key Results
- Achieves competitive classification performance (BAcc: 0.888±0.048) across four OCT datasets
- Demonstrates superior drusen detection with AP: 0.227 on OCT5K benchmark
- Provides more clinically relevant explanations compared to black-box and traditional prototypical methods
- Prototypes effectively capture key biomarkers while maintaining interpretability

## Why This Works (Mechanism)
The model works by leveraging the ViT backbone's ability to capture long-range dependencies among patches while using contrastive learning to enhance prototype quality. The multi-resolution pre-training strategy allows the model to learn robust features across different scales, while the prototype-based approach provides interpretable explanations by approximating lesion extent. The combination of patch-level and global-level representations through prototype learning creates a balance between classification performance and clinical interpretability.

## Foundational Learning
- **Vision Transformer fundamentals**: Understanding self-attention mechanisms and patch embedding is crucial for grasping how PiPViT processes OCT images. Quick check: Can you explain how patch embeddings preserve spatial relationships in OCT volumes?
- **Contrastive learning in medical imaging**: The method uses contrastive learning to enhance prototype quality, requiring knowledge of how augmentation strategies affect feature learning. Quick check: What augmentation strategies would be most effective for OCT images?
- **Prototype-based classification**: Understanding how prototypes approximate lesion extent rather than providing precise segmentation is key to interpreting results. Quick check: How do prototype-based methods differ from segmentation approaches in clinical utility?
- **Multi-resolution training**: The approach requires understanding how training across different resolutions improves generalizability. Quick check: Why is multi-resolution pre-training particularly important for OCT image analysis?

## Architecture Onboarding

**Component Map**: Input OCT images -> Patch Embedding -> ViT Backbone -> Prototype Layer -> Class Weights -> Classification Output

**Critical Path**: Image → Patch Embedding → ViT Backbone → Prototype Learning → Classification, where each component must function correctly for interpretable predictions.

**Design Tradeoffs**: The model balances interpretability (via prototypes) against maximum classification accuracy, accepts patch-based approximations rather than precise segmentation, and prioritizes clinically meaningful explanations over black-box performance.

**Failure Signatures**: Poor prototype quality manifests as clinically irrelevant regions being highlighted, classification performance drops when prototypes fail to capture key biomarkers, and interpretability suffers when prototypes become too abstract or too localized.

**Three First Experiments**:
1. Test prototype quality on OCT5K drusen detection benchmark to verify AP: 0.227 claim
2. Evaluate classification performance on OPTIMA5C dataset to confirm BAcc: 0.888±0.048
3. Assess prototype interpretability through qualitative comparison with clinician-identified biomarkers

## Open Questions the Paper Calls Out

### Open Question 1
- Question: Can a teacher-student self-supervised feature distillation framework improve the quality and robustness of learned prototypes in PiPViT?
- Basis in paper: The authors state "A promising direction for future improvement is to incorporate a teacher-student self-supervised feature distillation approach [61] to enhance contrastive learning... We believe that concurrently optimizing both patch-level and global-level representations can lead to more distinctive and meaningful prototype weights."
- Why unresolved: The current contrastive learning approach primarily aligns patch-level features but does not explicitly distill features from augmented views for diverse representations.
- What evidence would resolve it: A comparative study showing improved prototype semantic quality metrics (e.g., higher AP on biomarker detection tasks) and classification performance when integrating teacher-student distillation.

### Open Question 2
- Question: How can PiPViT's scoring mechanism be modified to consistently prioritize clinically critical biomarkers over less relevant regions (e.g., the vitreous)?
- Basis in paper: The authors acknowledge "its scoring mechanism may not always prioritize the most critical biomarkers, occasionally overemphasizing regions less clinically relevant for retinal diseases (e.g., the vitreous)."
- Why unresolved: The model learns prototype-class associations without explicit guidance on clinical importance, and the current sparsity regularization does not distinguish between clinically relevant and irrelevant regions.
- What evidence would resolve it: A modified loss function or constraint that yields qualitatively better biomarker prioritization and quantitatively higher alignment with clinician-identified critical regions.

### Open Question 3
- Question: Would integrating retinal layer segmentation improve PiPViT's biomarker localization without limiting its applicability to diseases affecting extra-retinal regions?
- Basis in paper: The authors note "Restricting the analysis to retinal layers could mitigate this issue, but would require extra segmentation and may not suit disease that affect the area outside the retina."
- Why unresolved: Retinal layer segmentation could refine biomarker localization but introduces dependency on segmentation accuracy and excludes extra-retinal pathologies.
- What evidence would resolve it: Experiments comparing PiPViT with and without layer-aware masking across diseases with both intra- and extra-retinal manifestations, measuring classification accuracy and prototype localization quality.

## Limitations
- Prototype-based approach may lag behind fully optimized black-box models in maximum predictive performance scenarios
- Fixed patch size may miss important pathological features at scales smaller or larger than chosen dimensions
- Prototype approximation of lesion extent rather than precise segmentation limits utility in cases requiring exact boundary delineation

## Confidence
**High Confidence** - Prototype interpretability claims and clinical relevance well-supported by quantitative evaluations on OCT5K (AP: 0.227 for drusen detection) and qualitative demonstrations across datasets.

**Medium Confidence** - Generalizability claims across four diverse datasets reasonable given multi-resolution pre-training, but sample sizes and disease spectrum coverage vary considerably between datasets.

**Low Confidence** - Long-term clinical utility claims require further validation; performance in real-world clinical workflows and physician acceptance remain untested.

## Next Checks
1. Conduct prospective clinical validation study comparing PiPViT's prototype-based explanations with expert ophthalmologist assessments on held-out test set containing diverse severity levels and rare pathologies.
2. Perform ablation studies systematically varying patch sizes and multi-resolution pre-training parameters to quantify impact on both classification performance and prototype quality across different OCT pathologies.
3. Implement user study with retinal specialists to evaluate clinical utility of prototype-based explanations for diagnostic decision-making, treatment planning, and monitoring disease progression over time.